Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Macrophage markers WP4146,0.0006935697297973648,24.75294117647059,180.04444781041695,"['CD163', 'CD14', 'CD68']",0.09831822394835037,0,0,3
2,Microglia Pathogen Phagocytosis Pathway WP3937,0.0008949012680559309,7.684087249304641,53.933049768727194,"['NCF2', 'ARPC1B', 'NCF4', 'ITGB2', 'CYBA']",0.09831822394835037,0,0,5
3,Hematopoietic Stem Cell Differentiation WP2849,0.0011893333542139157,7.152787242742265,48.169461000481036,"['RHOH', 'FOSB', 'ACVR1B', 'GATA1', 'RUNX1']",0.09831822394835037,0,0,5
4,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.0019374391586534309,15.466176470588236,96.60774219286138,"['ZAP70', 'CD4', 'HLA-DRB1']",0.12012122783651272,0,0,3
5,Vitamin D Receptor Pathway WP2877,0.0038579148250694646,3.404734693877551,18.922250372926154,"['LRRC25', 'COLEC11', 'CRACR2A', 'ALOX5', 'TNFAIP3', 'TNFRSF11B', 'CD14', 'HLA-DRB1']",0.16752101622962537,0,0,8
6,Cancer immunotherapy by PD-1 blockade WP4585,0.004052927812007065,11.244919786096256,61.94056868087039,"['ZAP70', 'HLA-DRB1', 'BATF']",0.16752101622962537,0,0,3
7,Cytosine methylation WP3585,0.008027151515991622,20.548828125,99.14656572405143,"['TDG', 'IDH2']",0.2488416969957403,0,0,2
8,Purine metabolism WP4792,0.008027151515991622,20.548828125,99.14656572405143,"['PNP', 'ITPA']",0.2488416969957403,0,0,2
9,TYROBP causal network in microglia WP3945,0.009181441322590057,4.225215778010809,19.81867493448847,"['CD4', 'NCF2', 'ITGB2', 'IL18', 'SLC1A5']",0.2529997164447038,0,0,5
10,Cytokines and Inflammatory Response WP530,0.022608161390811145,10.2705078125,38.919517436141255,"['CD4', 'HLA-DRB1']",0.46723533541009704,0,0,2
11,LTF danger signal response pathway WP4478,0.022608161390811145,10.2705078125,38.919517436141255,"['MAPK1', 'CD14']",0.46723533541009704,0,0,2
12,Purine metabolism and related disorders WP4224,0.022608161390811145,10.2705078125,38.919517436141255,"['PNP', 'ITPA']",0.46723533541009704,0,0,2
13,Ebola Virus Pathway on Host WP4217,0.02880003138606203,3.084773759660197,10.942861044129442,"['HLA-B', 'MAPK1', 'HLA-DOA', 'IKBKE', 'HLA-DRB1']",0.5494159833648756,0,0,5
14,T-cell receptor (TCR) signaling pathway WP69,0.03537945581442097,3.4373359580052494,11.486284235481646,"['ZAP70', 'CD4', 'MAPK1', 'CRKL']",0.6181441923055346,0,0,4
15,Kallmann's Syndrome WP5074,0.03738775356686701,7.467329545454546,24.540721970650754,"['MAPK1', 'GNRH1']",0.6181441923055346,0,0,2
16,Cytosolic DNA-sensing pathway WP4655,0.04031574335642787,4.2580121703853955,13.672533422441354,"['RNF125', 'IL18', 'IKBKE']",0.624894022024632,0,0,3
17,Modulators of TCR signaling and T cell activation WP5072,0.05416898403682031,3.7404634581105167,10.905870254469065,"['ZAP70', 'TNFAIP3', 'RHOH']",0.6506116262858765,0,0,3
18,Eicosanoid Synthesis WP167,0.05489390665143393,5.865513392857143,17.023789961665777,"['ALOX5', 'ALOX5AP']",0.6506116262858765,0,0,2
19,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.05489390665143393,5.865513392857143,17.023789961665777,"['MAPK1', 'HIST1H3E']",0.6506116262858765,0,0,2
20,Kit receptor signaling pathway WP304,0.06585706863041244,3.4277777777777776,9.32447595546252,"['DOK1', 'MAPK1', 'CRKL']",0.6506116262858765,0,0,3
21,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.07008198601756332,20.472762645914397,54.41843529128397,['CTDSP1'],0.6506116262858765,0,0,1
22,Complement system WP2806,0.07303356431775723,2.6576073152146305,6.954522917090123,"['FCGR3A', 'ITGB2', 'F11', 'VSIG4']",0.6506116262858765,0,0,4
23,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.07423575598525727,3.246749226006192,8.443201746233996,"['FZD9', 'MAPK1', 'NEFH']",0.6506116262858765,0,0,3
24,Allograft Rejection WP2328,0.08763575005725416,3.0083213773314204,7.323957720323825,"['HLA-B', 'HLA-DOA', 'HLA-DRB1']",0.6506116262858765,0,0,3
25,Glucocorticoid Receptor Pathway WP2880,0.08763575005725416,3.0083213773314204,7.323957720323825,"['GPR153', 'ALOX5AP', 'TNFAIP3']",0.6506116262858765,0,0,3
26,Common Pathways Underlying Drug Addiction WP2636,0.08892546106443946,4.3199013157894735,10.453974462059488,"['MAPK1', 'DRD1']",0.6506116262858765,0,0,2
27,Metabolism of alpha-linolenic acid WP4586,0.09233786860437596,13.647211413748378,32.51176463680945,['ALOX5'],0.6506116262858765,0,0,1
28,BDNF-TrkB Signaling WP3676,0.09632844897639203,4.103515625,9.602192025221548,"['DLG4', 'MAPK1']",0.6506116262858765,0,0,2
29,Signaling of Hepatocyte Growth Factor Receptor WP313,0.10389946024408031,3.9077380952380953,8.84841475918535,"['MAPK1', 'CRKL']",0.6506116262858765,0,0,2
30,Prion disease pathway WP3995,0.10389946024408031,3.9077380952380953,8.84841475918535,"['MAPK1', 'BATF']",0.6506116262858765,0,0,2
31,Amyotrophic lateral sclerosis (ALS) WP2447,0.1116262932515908,3.729758522727273,8.177863517318524,"['SLC1A2', 'NEFH']",0.6506116262858765,0,0,2
32,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.11406311687050766,10.23443579766537,22.218994167110406,['MAPK1'],0.6506116262858765,0,0,1
33,"Cerebral organic acidurias, including diseases WP4519",0.11406311687050766,10.23443579766537,22.218994167110406,['IDH2'],0.6506116262858765,0,0,1
34,Acute viral myocarditis WP4298,0.11716960792856526,2.622778473091364,5.623585229286925,"['CD4', 'ITGB2', 'MAPK1']",0.6506116262858765,0,0,3
35,Regulatory circuits of the STAT3 signaling pathway WP4538,0.11716960792856526,2.622778473091364,5.623585229286925,"['CSF3R', 'MAPK1', 'F2RL2']",0.6506116262858765,0,0,3
36,Sleep regulation WP3591,0.11949723000199111,3.567255434782609,7.5784989286188384,"['IL18', 'DRD1']",0.6506116262858765,0,0,2
37,Corticotropin-releasing hormone signaling pathway WP2355,0.12241389093987996,2.567892156862745,5.393465685179334,"['IL18', 'MAPK1', 'FOSB']",0.6506116262858765,0,0,3
38,Toll-like Receptor Signaling related to MyD88 WP3858,0.12750102015380263,3.4182942708333335,7.040424550654818,"['MAPK1', 'IKBKE']",0.6506116262858765,0,0,2
39,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.12750102015380263,3.4182942708333335,7.040424550654818,"['ITGB2', 'CD14']",0.6506116262858765,0,0,2
40,IL-2 signaling pathway WP49,0.12750102015380263,3.4182942708333335,7.040424550654818,"['MAPK1', 'CRKL']",0.6506116262858765,0,0,2
41,Regulation of toll-like receptor signaling pathway WP1449,0.13311670917905974,2.109226731273975,4.2533169195431775,"['TNFAIP3', 'MAPK1', 'CD14', 'IKBKE']",0.6506116262858765,0,0,4
42,Dual hijack model of Vif in HIV infection WP3300,0.13527033254405751,8.186770428015564,16.377470829308045,['RUNX1'],0.6506116262858765,0,0,1
43,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.14386440469110623,3.1547475961538463,6.116689818393711,"['DLG4', 'MAPK1']",0.6506116262858765,0,0,2
44,NO/cGMP/PKG mediated Neuroprotection WP4008,0.14386440469110623,3.1547475961538463,6.116689818393711,"['DLG4', 'CNGA3']",0.6506116262858765,0,0,2
45,Toll-like Receptor Signaling Pathway WP75,0.1555493725527863,2.2812636165577342,4.2449572914808575,"['MAPK1', 'CD14', 'IKBKE']",0.6506116262858765,0,0,3
46,Bile acids synthesis and enterohepatic circulation  WP4389,0.1559718200385607,6.82166018158236,12.675189864687226,['MAPK1'],0.6506116262858765,0,0,1
47,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.1559718200385607,6.82166018158236,12.675189864687226,['HSD11B2'],0.6506116262858765,0,0,1
48,Iron metabolism in placenta WP2007,0.1559718200385607,6.82166018158236,12.675189864687226,['HEPHL1'],0.6506116262858765,0,0,1
49,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.1559718200385607,6.82166018158236,12.675189864687226,['MAPK1'],0.6506116262858765,0,0,1
50,Metabolic reprogramming in colon cancer WP4290,0.1606352182264249,2.9288504464285716,5.35575218937652,"['IDH2', 'SLC1A5']",0.6506116262858765,0,0,2
51,Pre-implantation embryo WP3527,0.1606352182264249,2.9288504464285716,5.35575218937652,"['CELF3', 'FOSB']",0.6506116262858765,0,0,2
52,Proteasome Degradation WP183,0.1606352182264249,2.9288504464285716,5.35575218937652,"['HLA-B', 'PSMB8']",0.6506116262858765,0,0,2
53,IL-18 signaling pathway WP4754,0.1606612167342488,1.680919987042436,3.0734905469517146,"['NCF2', 'IL18', 'TNFAIP3', 'MAPK1', 'TNFRSF11B', 'GATA1']",0.6506116262858765,0,0,6
54,TNF-alpha signaling pathway WP231,0.16132310053761692,2.239572192513369,4.085754771262107,"['TNFAIP3', 'MAPK1', 'CYBA']",0.6506116262858765,0,0,3
55,ErbB signaling pathway WP673,0.16132310053761692,2.239572192513369,4.085754771262107,"['SHC3', 'MAPK1', 'CRKL']",0.6506116262858765,0,0,3
56,22q11.2 copy number variation syndrome WP4657,0.16716085306788658,2.19936974789916,3.9342298296878973,"['P2RX6', 'LRRC74B', 'CRKL']",0.6506116262858765,0,0,3
57,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.16914982621009111,2.8275862068965516,5.024537024734758,"['RNF125', 'IKBKE']",0.6506116262858765,0,0,2
58,Cancer immunotherapy by CTLA4 blockade WP4582,0.17617959304459027,5.846581434130072,10.151135137005715,['HLA-DRB1'],0.6506116262858765,0,0,1
59,IL-9 signaling pathway WP22,0.17617959304459027,5.846581434130072,10.151135137005715,['MAPK1'],0.6506116262858765,0,0,1
60,Osteoclast Signaling WP12,0.17617959304459027,5.846581434130072,10.151135137005715,['TNFRSF11B'],0.6506116262858765,0,0,1
61,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.17826690025048855,1.8677523264137437,3.220889227321405,"['CTDSP1', 'FZD9', 'MAPK1', 'WNT9A']",0.6506116262858765,0,0,4
62,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.186393658521811,2.644657258064516,4.442744912757026,"['ZAP70', 'CD4']",0.6506116262858765,0,0,2
63,p53 transcriptional gene network WP4963,0.186393658521811,2.644657258064516,4.442744912757026,"['NCF2', 'TNFRSF10D']",0.6506116262858765,0,0,2
64,B Cell Receptor Signaling Pathway WP23,0.19109490296449547,2.0519607843137253,3.395964524186594,"['MAPK1', 'PIK3AP1', 'CRKL']",0.6506116262858765,0,0,3
65,Interferon type I signaling pathways WP585,0.19510646625052117,2.561767578125,4.186465908568603,"['ZAP70', 'CRKL']",0.6506116262858765,0,0,2
66,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.19590538110451577,5.115272373540856,8.33852563226756,['IDH2'],0.6506116262858765,0,0,1
67,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.19590538110451577,5.115272373540856,8.33852563226756,['MAPK1'],0.6506116262858765,0,0,1
68,Osteoblast Signaling WP322,0.19590538110451577,5.115272373540856,8.33852563226756,['TNFRSF11B'],0.6506116262858765,0,0,1
69,Osteopontin Signaling WP1434,0.19590538110451577,5.115272373540856,8.33852563226756,['MAPK1'],0.6506116262858765,0,0,1
70,Integrin-mediated Cell Adhesion WP185,0.20337230024072303,1.9853889943074003,3.1621627796479106,"['SHC3', 'ITGB2', 'MAPK1']",0.6506116262858765,0,0,3
71,IL-3 signaling pathway WP286,0.20386950497005366,2.483901515151515,3.9500869076012024,"['MAPK1', 'CRKL']",0.6506116262858765,0,0,2
72,Pathogenic Escherichia coli infection WP2272,0.20386950497005366,2.483901515151515,3.9500869076012024,"['ARPC1B', 'CD14']",0.6506116262858765,0,0,2
73,3q29 copy number variation syndrome WP4906,0.21267542005867623,2.4106158088235294,3.7316046460009087,"['PIGM', 'DYNLRB2']",0.6506116262858765,0,0,2
74,Cardiac Hypertrophic Response WP2795,0.21267542005867623,2.4106158088235294,3.7316046460009087,"['MAPK1', 'IKBKE']",0.6506116262858765,0,0,2
75,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.21516063638966282,4.546476437527021,6.985071749400469,['MAPK1'],0.6506116262858765,0,0,1
76,"GPCRs, Class B Secretin-like WP334",0.21516063638966282,4.546476437527021,6.985071749400469,['ADGRE1'],0.6506116262858765,0,0,1
77,Immune response to tuberculosis WP4197,0.21516063638966282,4.546476437527021,6.985071749400469,['PSMB8'],0.6506116262858765,0,0,1
78,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.21516063638966282,4.546476437527021,6.985071749400469,['MAPK1'],0.6506116262858765,0,0,1
79,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.21516063638966282,4.546476437527021,6.985071749400469,['MAPK1'],0.6506116262858765,0,0,1
80,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.21516063638966282,4.546476437527021,6.985071749400469,['MAPK1'],0.6506116262858765,0,0,1
81,"GPCRs, Class A Rhodopsin-like WP455",0.21782621887380565,1.5926708949964763,2.4273223334791054,"['GPR65', 'OR7A5', 'GPR37L1', 'DRD1', 'F2RL2']",0.6506116262858765,0,0,5
82,MET in type 1 papillary renal cell carcinoma WP4205,0.22151717754205374,2.341517857142857,3.5292648291486945,"['MAPK1', 'CRKL']",0.6506116262858765,0,0,2
83,PPAR signaling pathway WP3942,0.22151717754205374,2.341517857142857,3.5292648291486945,"['DBI', 'CPT1B']",0.6506116262858765,0,0,2
84,RANKL/RANK signaling pathway WP2018,0.22151717754205374,2.341517857142857,3.5292648291486945,"['MAPK1', 'TNFRSF11B']",0.6506116262858765,0,0,2
85,ERK Pathway in Huntington's Disease WP3853,0.23395653997518864,4.091439688715953,5.943306742064216,['MAPK1'],0.6506116262858765,0,0,1
86,Fatty acid transporters WP5061,0.23395653997518864,4.091439688715953,5.943306742064216,['DBI'],0.6506116262858765,0,0,1
87,miR-509-3p alteration of YAP1/ECM axis WP3967,0.23395653997518864,4.091439688715953,5.943306742064216,['GPC6'],0.6506116262858765,0,0,1
88,SARS coronavirus and innate immunity WP4912,0.23395653997518864,4.091439688715953,5.943306742064216,['IKBKE'],0.6506116262858765,0,0,1
89,Selective expression of chemokine receptors during T-cell polarization WP4494,0.2523040083816869,3.7191368942341705,5.121699793610802,['CD4'],0.6506116262858765,0,0,1
90,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.2523040083816869,3.7191368942341705,5.121699793610802,['MAPK1'],0.6506116262858765,0,0,1
91,Cells and molecules involved in local acute inflammatory response  WP4493,0.2523040083816869,3.7191368942341705,5.121699793610802,['ITGB2'],0.6506116262858765,0,0,1
92,Development and heterogeneity of the ILC family WP3893,0.2523040083816869,3.7191368942341705,5.121699793610802,['IL18'],0.6506116262858765,0,0,1
93,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.2523040083816869,3.7191368942341705,5.121699793610802,['HIST1H3E'],0.6506116262858765,0,0,1
94,Hypertrophy Model WP516,0.2523040083816869,3.7191368942341705,5.121699793610802,['IL18'],0.6506116262858765,0,0,1
95,PPAR-alpha pathway WP2878,0.2523040083816869,3.7191368942341705,5.121699793610802,['DBI'],0.6506116262858765,0,0,1
96,Osteoblast differentiation WP4787,0.2605121055121034,1.7322286661143331,2.3300310830780995,"['FZD9', 'MAPK1', 'WNT9A']",0.6506116262858765,0,0,3
97,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.27021369962679553,3.4088845654993514,4.460669148461502,['MAPK1'],0.6506116262858765,0,0,1
98,Signal Transduction of S1P Receptor WP26,0.27021369962679553,3.4088845654993514,4.460669148461502,['MAPK1'],0.6506116262858765,0,0,1
99,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.27021369962679553,3.4088845654993514,4.460669148461502,['IKBKE'],0.6506116262858765,0,0,1
100,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.27021369962679553,3.4088845654993514,4.460669148461502,['ZAP70'],0.6506116262858765,0,0,1
101,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.27021369962679553,3.4088845654993514,4.460669148461502,['MAPK1'],0.6506116262858765,0,0,1
102,Type II diabetes mellitus WP1584,0.27021369962679553,3.4088845654993514,4.460669148461502,['MAPK1'],0.6506116262858765,0,0,1
103,Intraflagellar transport proteins binding to dynein WP4532,0.27021369962679553,3.4088845654993514,4.460669148461502,['DYNLRB2'],0.6506116262858765,0,0,1
104,Blood Clotting Cascade WP272,0.2876960195529876,3.146363364262197,3.9198994526727153,['F11'],0.6730241554562385,0,0,1
105,Fatty Acid Biosynthesis WP357,0.2876960195529876,3.146363364262197,3.9198994526727153,['ACAA2'],0.6730241554562385,0,0,1
106,Physiological and pathological hypertrophy of the heart WP1528,0.2876960195529876,3.146363364262197,3.9198994526727153,['MAPK1'],0.6730241554562385,0,0,1
107,Nuclear Receptors Meta-Pathway WP2882,0.29490062520645466,1.3530873888016746,1.6522778006527004,"['GPR153', 'SERPINA1', 'ALOX5AP', 'TNFAIP3', 'DBI', 'SLC5A3']",0.6730241554562385,0,0,6
108,EPO Receptor Signaling WP581,0.3047611275061499,2.921345191773207,3.471221226558015,['MAPK1'],0.6730241554562385,0,0,1
109,IL-7 signaling pathway WP205,0.3047611275061499,2.921345191773207,3.471221226558015,['MAPK1'],0.6730241554562385,0,0,1
110,Ras signaling WP4223,0.30709570902601435,1.4510487074071494,1.713102044669324,"['ZAP70', 'SHC3', 'MAPK1', 'RASAL3']",0.6730241554562385,0,0,4
111,Statin inhibition of cholesterol production WP430,0.3214189422942255,2.7263294422827498,3.0944108820100924,['APOC1'],0.6730241554562385,0,0,1
112,Cannabinoid receptor signaling WP3869,0.3214189422942255,2.7263294422827498,3.0944108820100924,['MAPK1'],0.6730241554562385,0,0,1
113,Ebstein-Barr virus LMP1 signaling WP262,0.3214189422942255,2.7263294422827498,3.0944108820100924,['MAPK1'],0.6730241554562385,0,0,1
114,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.3214189422942255,2.7263294422827498,3.0944108820100924,['MAPK1'],0.6730241554562385,0,0,1
115,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.3214189422942255,2.7263294422827498,3.0944108820100924,['MAPK1'],0.6730241554562385,0,0,1
116,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.3214189422942255,2.7263294422827498,3.0944108820100924,['MAPK1'],0.6730241554562385,0,0,1
117,Purinergic signaling WP4900,0.3214189422942255,2.7263294422827498,3.0944108820100924,['P2RX6'],0.6730241554562385,0,0,1
118,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.3370405265029928,1.7052408854166667,1.8545383045332362,"['MAPK1', 'IKBKE']",0.6730241554562385,0,0,2
119,7-oxo-C and 7beta-HC pathways WP5064,0.33767914780867125,2.5556906614785992,2.7746088264259483,['HSD11B2'],0.6730241554562385,0,0,1
120,TLR4 Signaling and Tolerance WP3851,0.33767914780867125,2.5556906614785992,2.7746088264259483,['IKBKE'],0.6730241554562385,0,0,1
121,Fatty acid beta-oxidation WP143,0.33767914780867125,2.5556906614785992,2.7746088264259483,['CPT1B'],0.6730241554562385,0,0,1
122,Angiogenesis WP1539,0.3535511986282002,2.40512703135729,2.500675442395916,['MAPK1'],0.6730241554562385,0,0,1
123,Base Excision Repair WP4752,0.3535511986282002,2.40512703135729,2.500675442395916,['TDG'],0.6730241554562385,0,0,1
124,Estrogen signaling pathway WP712,0.3535511986282002,2.40512703135729,2.500675442395916,['MAPK1'],0.6730241554562385,0,0,1
125,IL1 and megakaryocytes in obesity WP2865,0.3535511986282002,2.40512703135729,2.500675442395916,['IL18'],0.6730241554562385,0,0,1
126,Nanoparticle-mediated activation of receptor signaling WP2643,0.3535511986282002,2.40512703135729,2.500675442395916,['MAPK1'],0.6730241554562385,0,0,1
127,RAS and bradykinin pathways in COVID-19 WP4969,0.3535511986282002,2.40512703135729,2.500675442395916,['MAPK1'],0.6730241554562385,0,0,1
128,"Relationship between inflammation, COX-2 and EGFR WP4483",0.3535511986282002,2.40512703135729,2.500675442395916,['MAPK1'],0.6730241554562385,0,0,1
129,Chemokine signaling pathway WP3929,0.35884813318619346,1.4280437756497948,1.4635392422072948,"['SHC3', 'MAPK1', 'CRKL']",0.6730241554562385,0,0,3
130,Prolactin Signaling Pathway WP2037,0.36320431941053816,1.6044730392156863,1.6249938317037025,"['ZAP70', 'MAPK1']",0.6730241554562385,0,0,2
131,Type II interferon signaling (IFNG) WP619,0.3690443253172466,2.2712926934716817,2.264112045558998,['HLA-B'],0.6730241554562385,0,0,1
132,Disruption of postsynaptic signaling by CNV WP4875,0.3690443253172466,2.2712926934716817,2.264112045558998,['MAPK1'],0.6730241554562385,0,0,1
133,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.3690443253172466,2.2712926934716817,2.264112045558998,['ALOX5'],0.6730241554562385,0,0,1
134,Fluoropyrimidine Activity WP1601,0.3690443253172466,2.2712926934716817,2.264112045558998,['TDG'],0.6730241554562385,0,0,1
135,Inflammatory Response Pathway WP453,0.3690443253172466,2.2712926934716817,2.264112045558998,['ZAP70'],0.6730241554562385,0,0,1
136,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3719407151347183,1.3953208556149732,1.3800013563096427,"['SHC3', 'NCF2', 'MAPK1']",0.6730241554562385,0,0,3
137,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.38416753982880314,2.151546180626664,2.058333712504957,['TNFRSF11B'],0.6730241554562385,0,0,1
138,GABA receptor Signaling WP4159,0.38416753982880314,2.151546180626664,2.058333712504957,['GABRA4'],0.6730241554562385,0,0,1
139,Resistin as a regulator of inflammation WP4481,0.38416753982880314,2.151546180626664,2.058333712504957,['MAPK1'],0.6730241554562385,0,0,1
140,SARS-CoV-2 mitochondrial interactions WP5038,0.38416753982880314,2.151546180626664,2.058333712504957,['IKBKE'],0.6730241554562385,0,0,1
141,Focal Adhesion WP306,0.3887907518883329,1.2791584645669292,1.2084389007077596,"['SHC3', 'MAPK1', 'MYL12A', 'CRKL']",0.6730241554562385,0,0,4
142,Selenium Micronutrient Network WP15,0.38897171098807254,1.5149016203703705,1.4304438256782575,"['ALOX5', 'ALOX5AP']",0.6730241554562385,0,0,2
143,Breast cancer pathway WP4262,0.3979633344127234,1.3341432225063938,1.2292734315373886,"['SHC3', 'FZD9', 'MAPK1']",0.6730241554562385,0,0,3
144,Wnt signaling in kidney disease WP4150,0.39892964053252844,2.0437743190661477,1.8781677298169959,['FZD9'],0.6730241554562385,0,0,1
145,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.39892964053252844,2.0437743190661477,1.8781677298169959,['GABRA4'],0.6730241554562385,0,0,1
146,Monoamine Transport WP727,0.39892964053252844,2.0437743190661477,1.8781677298169959,['TNFRSF11B'],0.6730241554562385,0,0,1
147,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.39892964053252844,2.0437743190661477,1.8781677298169959,['MAPK1'],0.6730241554562385,0,0,1
148,Heart Development WP1591,0.4133392174250472,1.946266444320919,1.719500466534087,['MAPK1'],0.6730830823791094,0,0,1
149,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.4133392174250472,1.946266444320919,1.719500466534087,['IKBKE'],0.6730830823791094,0,0,1
150,MAPK Cascade WP422,0.4133392174250472,1.946266444320919,1.719500466534087,['MAPK1'],0.6730830823791094,0,0,1
151,miRNA regulation of prostate cancer signaling pathways WP3981,0.4133392174250472,1.946266444320919,1.719500466534087,['MAPK1'],0.6730830823791094,0,0,1
152,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4142698174953531,1.4347587719298245,1.26436364126943,"['SHC3', 'MAPK1']",0.6730830823791094,0,0,2
153,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.42740465685762224,1.8576229218252565,1.5790241415003738,['IKBKE'],0.6730830823791094,0,0,1
154,Endothelin Pathways WP2197,0.42740465685762224,1.8576229218252565,1.5790241415003738,['MAPK1'],0.6730830823791094,0,0,1
155,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.42740465685762224,1.8576229218252565,1.5790241415003738,['MAPK1'],0.6730830823791094,0,0,1
156,IL17 signaling pathway WP2112,0.42740465685762224,1.8576229218252565,1.5790241415003738,['MAPK1'],0.6730830823791094,0,0,1
157,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.42740465685762224,1.8576229218252565,1.5790241415003738,['RAB13'],0.6730830823791094,0,0,1
158,Insulin Signaling WP481,0.4300645505321555,1.2647665251667677,1.0672352437907766,"['SHC3', 'RHOJ', 'MAPK1']",0.6730830823791094,0,0,3
159,CAMKK2  Pathway WP4874,0.4411341464890846,1.776687531720521,1.4540522028934142,['MAPK1'],0.6730830823791094,0,0,1
160,G13 Signaling Pathway WP524,0.4411341464890846,1.776687531720521,1.4540522028934142,['ARHGDIB'],0.6730830823791094,0,0,1
161,Histone Modifications WP2369,0.4411341464890846,1.776687531720521,1.4540522028934142,['HIST1H3E'],0.6730830823791094,0,0,1
162,PDGF Pathway WP2526,0.4411341464890846,1.776687531720521,1.4540522028934142,['MAPK1'],0.6730830823791094,0,0,1
163,Alpha 6 Beta 4 signaling pathway WP244,0.454535679921674,1.702496757457847,1.3423827105912327,['MAPK1'],0.6730830823791094,0,0,1
164,Bladder cancer WP2828,0.454535679921674,1.702496757457847,1.3423827105912327,['MAPK1'],0.6730830823791094,0,0,1
165,Notch Signaling WP268,0.454535679921674,1.702496757457847,1.3423827105912327,['DTX3'],0.6730830823791094,0,0,1
166,EGF/EGFR signaling pathway WP437,0.4615385206011647,1.2021914648212226,0.9295221304769085,"['MAPK1', 'FOSB', 'CRKL']",0.6730830823791094,0,0,3
167,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.4676170612325855,1.6342412451361867,1.242195862103235,['MAPK1'],0.6730830823791094,0,0,1
168,IL-6 signaling pathway WP364,0.4676170612325855,1.6342412451361867,1.242195862103235,['MAPK1'],0.6730830823791094,0,0,1
169,Regulation of Microtubule Cytoskeleton WP2038,0.4676170612325855,1.6342412451361867,1.242195862103235,['F2RL2'],0.6730830823791094,0,0,1
170,Fragile X Syndrome  WP4549,0.4711521852340532,1.2769775390625,0.9610202557065562,"['DLG4', 'MAPK1']",0.6730830823791094,0,0,2
171,Apoptosis Modulation and Signaling WP1772,0.4790083359475283,1.2572115384615385,0.9253545597827786,"['TNFRSF11B', 'TNFRSF10D']",0.6730830823791094,0,0,2
172,ESC Pluripotency Pathways WP3931,0.4790083359475283,1.2572115384615385,0.9253545597827786,"['FZD9', 'MAPK1']",0.6730830823791094,0,0,2
173,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.48038590960121924,1.5712361568392696,1.1519761735975778,['MAPK1'],0.6730830823791094,0,0,1
174,Fas ligand pathway and stress induction of heat shock proteins WP314,0.48038590960121924,1.5712361568392696,1.1519761735975778,['ARHGDIB'],0.6730830823791094,0,0,1
175,Interleukin-11 Signaling Pathway WP2332,0.48038590960121924,1.5712361568392696,1.1519761735975778,['MAPK1'],0.6730830823791094,0,0,1
176,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.48038590960121924,1.5712361568392696,1.1519761735975778,['MAPK1'],0.6730830823791094,0,0,1
177,Neovascularisation processes WP4331,0.48038590960121924,1.5712361568392696,1.1519761735975778,['MAPK1'],0.6730830823791094,0,0,1
178,Wnt Signaling Pathway WP363,0.4928496635020545,1.512898112119902,1.0704527137816102,['MAPK1'],0.6790373141583862,0,0,1
179,IL-5 signaling pathway WP127,0.4928496635020545,1.512898112119902,1.0704527137816102,['MAPK1'],0.6790373141583862,0,0,1
180,Neural Crest Cell Migration during Development WP4564,0.4928496635020545,1.512898112119902,1.0704527137816102,['F2RL2'],0.6790373141583862,0,0,1
181,Monoamine GPCRs WP58,0.5050155849793959,1.4587270705947748,0.9965527216271137,['DRD1'],0.6919550556623768,0,0,1
182,Neural Crest Cell Migration in Cancer WP4565,0.5168907640181997,1.4082919629679325,0.9293652639559605,['F2RL2'],0.6971466296663242,0,0,1
183,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5284821224889877,1.361219195849546,0.8681125071847196,['DBI'],0.6971466296663242,0,0,1
184,Aryl Hydrocarbon Receptor Netpath WP2586,0.5284821224889877,1.361219195849546,0.8681125071847196,['MAPK1'],0.6971466296663242,0,0,1
185,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.5284821224889877,1.361219195849546,0.8681125071847196,['MAPK1'],0.6971466296663242,0,0,1
186,Vitamin A and carotenoid metabolism WP716,0.5284821224889877,1.361219195849546,0.8681125071847196,['MAPK1'],0.6971466296663242,0,0,1
187,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5284821224889877,1.361219195849546,0.8681125071847196,['ITGB2'],0.6971466296663242,0,0,1
188,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5284821224889877,1.361219195849546,0.8681125071847196,['IL18'],0.6971466296663242,0,0,1
189,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.5397964178535537,1.317183381448475,0.8121268197289094,['MAPK1'],0.7083042943263561,0,0,1
190,Genotoxicity pathway WP4286,0.5508402475689511,1.2758998054474708,0.7608323790831739,['AMER1'],0.7152271277335073,0,0,1
191,Phosphodiesterases in neuronal function WP4222,0.5508402475689511,1.2758998054474708,0.7608323790831739,['DRD1'],0.7152271277335073,0,0,1
192,IL-4 signaling pathway WP395,0.5721421206300759,1.2006179903868162,0.6703864929560979,['MAPK1'],0.7185986195494359,0,0,1
193,Prostaglandin Synthesis and Regulation WP98,0.5721421206300759,1.2006179903868162,0.6703864929560979,['HSD11B2'],0.7185986195494359,0,0,1
194,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.5743227816419884,1.0463741987179487,0.5802811507409503,"['SHC3', 'MAPK1']",0.7185986195494359,0,0,2
195,TGF-beta Signaling Pathway WP366,0.5743227816419884,1.0463741987179487,0.5802811507409503,"['MAPK1', 'FOSB']",0.7185986195494359,0,0,2
196,Hippo-Merlin Signaling Dysregulation WP4541,0.581109364532953,1.0330300632911393,0.560745561752316,"['ITGB2', 'CDH13']",0.7185986195494359,0,0,2
197,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.5824125908445026,1.1662034463590885,0.6304217848212634,['MAPK1'],0.7185986195494359,0,0,1
198,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5824125908445026,1.1662034463590885,0.6304217848212634,['MAPK1'],0.7185986195494359,0,0,1
199,IL-1 signaling pathway WP195,0.5824125908445026,1.1662034463590885,0.6304217848212634,['MAPK1'],0.7185986195494359,0,0,1
200,Lung fibrosis WP3624,0.5824125908445026,1.1662034463590885,0.6304217848212634,['SERPINA1'],0.7185986195494359,0,0,1
201,Netrin-UNC5B signaling pathway WP4747,0.5824125908445026,1.1662034463590885,0.6304217848212634,['MAPK1'],0.7185986195494359,0,0,1
202,Synaptic Vesicle Pathway WP2267,0.5924374564139882,1.133700821444012,0.5935036834080546,['SLC17A6'],0.7273489563894507,0,0,1
203,NRF2 pathway WP2884,0.6009915660169124,0.9949504573170732,0.506603280041397,"['SERPINA1', 'SLC5A3']",0.7342162973999719,0,0,2
204,Spinal Cord Injury WP2431,0.6074596366780818,0.9828689759036144,0.48993025382472416,"['TNFSF13', 'MAPK1']",0.7365041862441044,0,0,2
205,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.6117736385737319,1.0738275650215032,0.5276712804713516,['TNFRSF11B'],0.7365041862441044,0,0,1
206,Oncostatin M Signaling Pathway WP2374,0.6117736385737319,1.0738275650215032,0.5276712804713516,['MAPK1'],0.7365041862441044,0,0,1
207,Prader-Willi and Angelman Syndrome WP3998,0.630195828444549,1.019941634241245,0.470932213567332,['GNRH1'],0.7550172244166578,0,0,1
208,AMP-activated protein kinase (AMPK) signaling WP1403,0.6390777071255312,0.9949701053430767,0.44547719376840555,['CPT1B'],0.7583314419479987,0,0,1
209,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6390777071255312,0.9949701053430767,0.44547719376840555,['MAPK1'],0.7583314419479987,0,0,1
210,Regulation of Actin Cytoskeleton WP51,0.6446006475440259,0.9160814606741573,0.4022736347731538,"['MAPK1', 'CD14']",0.761242669480564,0,0,2
211,Complement and Coagulation Cascades WP558,0.6477470687961198,0.9711876968686307,0.4217430985015934,['SERPINA1'],0.7613330476845388,0,0,1
212,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6562089790370913,0.9485114469278798,0.399585084758735,['MAPK1'],0.7629081435087163,0,0,1
213,Hepatitis B infection WP4666,0.662108537119081,0.8859544836956522,0.36530187630904976,"['MAPK1', 'IKBKE']",0.7629081435087163,0,0,2
214,Endometrial cancer WP4155,0.6644683830559787,0.9268659356207994,0.37887311809938035,['MAPK1'],0.7629081435087163,0,0,1
215,Melanoma WP4685,0.6644683830559787,0.9268659356207994,0.37887311809938035,['MAPK1'],0.7629081435087163,0,0,1
216,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6644683830559787,0.9268659356207994,0.37887311809938035,['MAPK1'],0.7629081435087163,0,0,1
217,VEGFA-VEGFR2 Signaling Pathway WP3888,0.668573726334877,0.8874458874458875,0.35729334836679044,"['DOK1', 'PNP', 'NCF2', 'RHOJ', 'IDH2', 'MAPK1']",0.7640842586684308,0,0,6
218,16p11.2 proximal deletion syndrome WP4949,0.680398869375569,0.8863982405684318,0.34133075994530426,['SPN'],0.7704973497951649,0,0,1
219,AGE/RAGE pathway WP2324,0.680398869375569,0.8863982405684318,0.34133075994530426,['MAPK1'],0.7704973497951649,0,0,1
220,Alzheimer's disease WP2059,0.6880792661087991,0.8674559152247703,0.32429946549050265,['MAPK1'],0.7721432488460732,0,0,1
221,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6880792661087991,0.8674559152247703,0.32429946549050265,['MAPK1'],0.7721432488460732,0,0,1
222,Non-small cell lung cancer WP4255,0.695575790981367,0.8493028534370947,0.30830993028603676,['MAPK1'],0.7770396223575631,0,0,1
223,Leptin signaling pathway WP2034,0.7028928291607635,0.8318907329468752,0.29328378221555507,['MAPK1'],0.7782027751422739,0,0,1
224,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7028928291607635,0.8318907329468752,0.29328378221555507,['FZD9'],0.7782027751422739,0,0,1
225,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7202788645246189,0.8171566493886757,0.2681228495073864,"['CSF3R', 'CAB39L', 'ITGB2', 'MAPK1']",0.7939073706760243,0,0,4
226,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7238093281802688,0.783672553127806,0.25330434787452305,['FZD9'],0.7942686433128613,0,0,1
227,MAPK Signaling Pathway WP382,0.7451331862903198,0.7719285182427401,0.22709542856146947,"['MAPK1', 'CD14', 'CRKL']",0.8140662123347987,0,0,3
228,Glioblastoma signaling pathways WP2261,0.7494335607266506,0.7274180100055586,0.2098147123955252,['MAPK1'],0.8151733467553042,0,0,1
229,DNA Repair Pathways Full Network WP4946,0.7554605754870246,0.7145880264864496,0.20039026383141093,['TDG'],0.8173727500107245,0,0,1
230,Thermogenesis WP4321,0.7613431663406345,0.7022004561921374,0.1914697577839166,['CPT1B'],0.8173727500107245,0,0,1
231,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7613431663406345,0.7022004561921374,0.1914697577839166,['MAPK1'],0.8173727500107245,0,0,1
232,Wnt signaling pathway and pluripotency WP399,0.7670847810080537,0.6902328035349206,0.18302071373031328,['FZD9'],0.8198618670188487,0,0,1
233,Circadian rhythm related genes WP3594,0.774176202605139,0.7072010869565217,0.18101220537376134,"['DRD1', 'CIART']",0.8198618670188487,0,0,2
234,7q11.23 copy number variation syndrome WP4932,0.7781584644148257,0.6674746443834917,0.16741939027121377,['FZD9'],0.8198618670188487,0,0,1
235,Senescence and Autophagy in Cancer WP615,0.7834970261430125,0.6566461654324087,0.16021379301584796,['MAPK1'],0.8198618670188487,0,0,1
236,Pancreatic adenocarcinoma pathway WP4263,0.7834970261430125,0.6566461654324087,0.16021379301584796,['MAPK1'],0.8198618670188487,0,0,1
237,Pathways in clear cell renal cell carcinoma WP4018,0.7834970261430125,0.6566461654324087,0.16021379301584796,['CDH13'],0.8198618670188487,0,0,1
238,Male infertility WP4673,0.7987569474901384,0.6261598323855133,0.14069722229407025,['LRWD1'],0.8323181637712367,0,0,1
239,Wnt signaling WP428,0.8036016148479539,0.6166136068859804,0.13482357424998045,['FZD9'],0.8338627635242367,0,0,1
240,Pathways Regulating Hippo Signaling WP4540,0.808330093113373,0.6073523433416574,0.12923533039128954,['CDH13'],0.8352744295504855,0,0,1
241,DNA damage response (only ATM dependent) WP710,0.8218458241511227,0.5811561978877154,0.11402427763286374,['MAPK1'],0.8457168646866324,0,0,1
242,Gastrin signaling pathway WP4659,0.8422947393685487,0.5421530479896238,0.09304716824980604,['MAPK1'],0.8631780800140498,0,0,1
243,Ectoderm Differentiation WP2858,0.873388364873087,0.48364832314248657,0.06547387223837547,['TNFRSF11B'],0.8877062069201869,0,0,1
244,Integrated breast cancer pathway WP1984,0.873388364873087,0.48364832314248657,0.06547387223837547,['MAPK1'],0.8877062069201869,0,0,1
245,Metapathway biotransformation Phase I and II WP702,0.88233026084989,0.46683662060020575,0.058442738575857835,['CHST10'],0.8931343048602968,0,0,1
246,PI3K-Akt signaling pathway WP4172,0.8958803895062097,0.5668499175371083,0.062324223772303795,"['CSF3R', 'MAPK1', 'PIK3AP1']",0.9031639699086992,0,0,3
247,Ciliopathies WP4803,0.9406598193945396,0.35222466587717816,0.02154689112680518,['DNAAF3'],0.944468158744315,0,0,1
248,Ciliary landscape WP4352,0.9512182195136548,0.3290626680585872,0.01645700961255742,['DYNLRB2'],0.9512182195136548,0,0,1
